%0 Journal Article
%T Medication development in opioid addiction: Meaningful clinical end points
%J -
%D 2018
%R 10.1126/scitranslmed.aan2595
%X The FDA¡¯s ¡°abstinence¡± outcome measure for approval of new medications to treat opioid-use disorders has been difficult to achieve; developing and validating alternative meaningful outcomes could facilitate drug development
%U http://stm.sciencemag.org/content/10/434/eaan2595